First-line ribociclib plus letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-2 safety results.
暂无分享，去创建一个
B. Ramaswamy | K. Blackwell | J. Sparano | L. Hart | H. Burris | D. Yardley | W. Janni | E. Alba | T. Bachelot | P. Conte | J. Kattan | A. Chan | S. Sutradhar | D. Richards | M. G. Gil Gil | H. Burris | A. Nusch | H. Bourgeois | M. Gil | F. Karak | O. Burdaeva | M. Miller | M. Miller | A. Chan | Kimberly L. Blackwell | Lowell L. Hart | Pierfranco Conte | Donald A. Richards | H. Bourgeois | Fadi Rafic El Karak